Exelixis, Inc.
EXEL · NASDAQ
1/3/2025 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $2 | $1 |
| % Growth | 18.5% | 13.6% | 12.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $2 | $2 | $2 | $1 |
| % Margin | 96.5% | 96% | 96.4% | 96.3% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $0 | $1 | $0 | $0 |
| SG&A Expenses | $0 | $1 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | -$0 |
| Operating Expenses | $1 | $2 | $1 | $1 |
| Operating Income | $1 | $0 | $0 | $0 |
| % Margin | 27.9% | 9.3% | 12.5% | 20% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $1 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | $0 | $0 | $0 |
| % Margin | 24% | 11.4% | 11.3% | 16.1% |
| EPS | 1.8 | 0.65 | 0.57 | 0.73 |
| % Growth | 176.9% | 14% | -21.9% | – |
| EPS Diluted | 1.76 | 0.65 | 0.56 | 0.72 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $0 | $0 | $0 |
| % Margin | 33.1% | 10.7% | 13.8% | 20.9% |